Switzerland's Sandoz files antitrust lawsuit against Amgen in US
Tweet
Share
E-mail
The logo of Amgen and a robot miniature are seen in this illustration taken, July 17, 2023. REUTERS/Dado Ruvic/Illustration
(Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept).
(Reporting by Abinaya Vijayaraghavan; Editing by Rashmi Aich)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin will draft 300,000 new troops after September elections, Zelenskiy says
- Germany's Merz to press cabinet for faster pro-growth reforms
- Motor racing- Palou claims seventh IndyCar pole of season in Washington
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
